abstract |
The present invention provides a novel class of compounds, pharmaceutical compositions comprising said compounds and methods using said compounds for the treatment or prevention of diseases or conditions associated with abnormal or deregulated kinase activity, particularly diseases or conditions that involve abnormal activation. of Abl, Bcr-Abl, FGFR3, PDGRF and b-Raf kinases. |